GALECTO BIOTECH ApS: Financial statements 2015
CVR: 34878366
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2015. In 2015, the company reported a gross profit of EUR 864,833 and a net result of EUR -503,972 compared with DKK -11,988,254 the year before. Equity in the 2015 report amounted to EUR -4,599,671.
- Gross Profit
- EUR 864,833
- Profit/Loss
- EUR -503,972
- Equity
- EUR -4,599,671
- Total Assets
- EUR 3,657,934
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 865 t. EUR | -504 t. EUR | -4.6 mio. EUR | - |
| 2014 | - | -15 mio. | -12 mio. | -30.6 mio. | - |
| 2013 | - | -15 mio. | -17.1 mio. | -18.6 mio. | - |
How creditworthy is GALECTO BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
GALECTO BIOTECH ApS has published its annual report for 2014. Gross profit came to DKK -15,028,765, and the net result was DKK -11,988,254.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.